[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366220-105":59,"doc-detail-366220-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","fabrication-and-appraisal-of-targeted-axitinib-loaded-bilosomes-for-the-enhanced-breast-and-ovarian-anticancer-activity","Fabrication and appraisal of targeted axitinib loaded bilosomes for the enhanced breast and ovarian anticancer activity","","A study formulates and optimizes bilosomal formulations of axitinib (AXT) to enhance targeted anticancer efficacy. A central composite rotatable design with Design-Expert software evaluates cholesterol, span 60, and sodium deoxy cholate (SDC) as formulation factors and measures entrapment efficiency (EE%), vesicle size (VS), and zeta potential (ZP). The optimized bilosomes are characterized by DSC, XRD, TEM, in-vitro release, short-term stability, and in-vitro cell proliferation with flow cytometry on MCF-7 and OV-2774 lines.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/fabrication-and-appraisal-of-targeted-axitinib-loaded-bilosomes-for-the-enhanced-breast-and-ovarian-anticancer-activity/366220/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/fabrication-and-appraisal-of-targeted-axitinib-loaded-bilosomes-for-the-enhanced-breast-and-ovarian-anticancer-activity/366220.png","ImageObject",300,407,{"name":92,"@type":93},"Cipher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of the bilosomal formulation in this study?","Question",{"text":112,"@type":113},"The study aims to formulate and statistically optimize axitinib-loaded bilosomes to improve anticancer efficacy in a targeted manner.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which formulation variables and response metrics are optimized?",{"text":117,"@type":113},"Cholesterol, span 60, and sodium deoxy cholate (SDC) are used as factors, while entrapment efficiency (EE%), vesicles’ size (VS), and zeta potential (ZP) serve as dependent responses.",{"name":119,"@type":110,"acceptedAnswer":120},"How is the optimized formulation evaluated for anticancer performance?",{"text":121,"@type":113},"Characterization includes DSC, XRD, and TEM, followed by in-vitro release, short-term stability, in-vitro cell proliferation assays, and flow cytometry on MCF-7 and OV-2774 cancer cell lines.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366220,1790865956,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","OPEN ACCESS  \nCitation: Zaki RM, Aldosari BN, Alkharashi LA, Alsalhi A, Abo El-Ela FI, Alosaimi RM, et al.(2025) Fabrication and appraisal of targeted axitinib loaded bilosomes for the enhanced breast and ovarian anticancer activity. PLoSOne 20(7): e0325511. [https://doi.org/10.1371/](https://doi.org/10.1371/)[ ](https://doi.org/10.1371/)[journal.pone.0325511](journal.pone.0325511)  \nEditor: Ahmed A. Al-Karmalawy, University of Mashreq, IRAQ  \nReceived: January 21, 2025  \nAccepted: May 14, 2025  \nPublished: July 17, 2025  \nCopyright: © 2025 Zaki et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: All relevant data are within the paper and its Supporting  Information files.  \nFunding: This study is supported via funding from Prince Sattam Bin Abdulaziz University Project number (PSAU/2025/R/1446). Also,  \nRESEARCH ARTICLE  \nFabrication and appraisal of targeted axitinib loaded bilosomes for the enhanced breast and ovarian anticancer activity  \nRanda Mohammed Zaki1,2*, Basmah Nasser Aldosari3, Layla A. Alkharashi4, Alyaa Alsalhi3, Fatma I. Abo El-Ela5, Raneem Meshal Alosaimi1, Maha Alsunbul6, Obaid Afzal7, Mayada Said8  \n1 Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia, 2 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt, 3 Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia, 4 Department of Pharmacology and toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia, 5 Department of pharmacology, Faculty of Veterinary Medicine, BeniSuef University, Beni-Suef, Egypt, 6 Department of Pharmaceutical Sciences. , College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia, 7 Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia,  \n8 Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt  \n* [r.abdelrahman@psau.edu.sa](r.abdelrahman@psau.edu.sa)  \nAbstract  \nThe goal of this study was the formulation and optimization by statistical means of bilosomal formulations of axitinib (AXT) in order to improve its anticancer efficacy in a targeted manner. A central composite rotatable design was employed Using Design-Expert® software. The formulation factors were cholesterol, span 60, and sodium deoxy cholate (SDC) amounts (mg), whereas the dependent responses were Entrapment efficiency (EE%), Vesicles’ size (VS), and Zeta potential (ZP) . The design expert software was utilized to perform the numerical optimization process. The optimized bilosomal formulation was assessed using differential scanning calorimetry (DSC), X-ray diffraction (XRD), transmission electron microscope (TEM), in-vitro release study, short-term stability study, and in-vitro cell proliferation assay and flow cytometry on MCF-7 breast and OV-2774 ovarian cancer cell lines. The optimized formulation was found to be composed of 19.999, 111.869 and 15 mgs of cholesterol, span 60, and SDC, respectively with a desirability of 0.753. EE%, VS, and ZP were predicted to be 88.4977%, 594.592 nm, and −44.2354 mV, respectively. The validation process on the optimized formula demonstrated that the variation from the predicted responses was less than 5% . The DSC and XRD studies revealed that AXT was entrapped within the bilosomal vesicles. The optimized AXT bilosomal formulation exhibited spherical non-aggregated nanovesicles in TEM images. Furthermore, it improved AXT release when compared toAXT suspension. According to stability experiments, the optimum bilosomal formulation was stable for thirty days.  \nPLOS One | [https://doi.org/10.1371","cbCaid0Xk8lJabNN","https://ap.wps.com/l/cbCaid0Xk8lJabNN","pdf",769494,"English","# Abstract\n## Introduction\n## Materials and Methods\n## Results and Discussion\n## Conclusion","[{\"question\":\"What is the purpose of the bilosomal formulation in this study?\",\"answer\":\"The study aims to formulate and statistically optimize axitinib-loaded bilosomes to improve anticancer efficacy in a targeted manner.\"},{\"question\":\"Which formulation variables and response metrics are optimized?\",\"answer\":\"Cholesterol, span 60, and sodium deoxy cholate (SDC) are used as factors, while entrapment efficiency (EE%), vesicles’ size (VS), and zeta potential (ZP) serve as dependent responses.\"},{\"question\":\"How is the optimized formulation evaluated for anticancer performance?\",\"answer\":\"Characterization includes DSC, XRD, and TEM, followed by in-vitro release, short-term stability, in-vitro cell proliferation assays, and flow cytometry on MCF-7 and OV-2774 cancer cell lines.\"}]","Fabrication and appraisal of targeted axitinib loaded bilosomes for the enhanced breast and ovarian anticancer activity | PDF",1790164289,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1a709082671c029db49d6c22239c558b.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/84806e5d29dea0df39648cb7afcdfbc5.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/58ad17a5833feed9bdef2af01cb8663f.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/13b55b1f6bb1925732523f8b42e40654.webp",980,1268]